Volume 28, Issue 9 pp. 1509-1520
ORIGINAL ARTICLE

Long-term outcomes of crossmatch positive simultaneous liver–kidney transplantations in the United States

Samy Riad

Corresponding Author

Samy Riad

Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

Correspondence

Samy Riad, Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota, 717 Delaware St SE, MMC 1932, Suite 353, Minneapolis, MN 55414, USA.

Email: [email protected]

Search for more papers by this author
Elizabeth S. Aby

Elizabeth S. Aby

Division of Gastroenterology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

Search for more papers by this author
Phuoc Le Nguyen

Phuoc Le Nguyen

Division of Transplant Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA

Search for more papers by this author
Scott Jackson

Scott Jackson

Complex Care Analytics, MHealth Fairview, Minneapolis, Minnesota, USA

Search for more papers by this author
Nicholas Lim

Nicholas Lim

Division of Gastroenterology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

Search for more papers by this author
John Lake

John Lake

Division of Gastroenterology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

Search for more papers by this author
First published: 18 February 2022
Citations: 1

Samy Riad and Elizabeth S. Aby are co-first authors.

Abstract

The long-term outcomes of positive crossmatch (+XM) simultaneous liver–kidney (SLK) transplantations are conflicting. We examined the association between crossmatch status and SLK outcomes in recipients discharged on tacrolimus and mycophenolate with or without steroids. We analyzed the Scientific Registry of Transplant Recipients for all primary SLK recipients between 2003 and 2020 with available crossmatch and induction data. We grouped recipients according to the crossmatch status: negative crossmatch (−XM; n = 3040) and +XM (n = 407). Kaplan–Meier curves were generated to examine recipient, death-censored liver, and death-censored kidney survival by crossmatch status. Cox proportional hazard models were used to investigate the association between crossmatch status and outcomes of interest with follow-up censored at 10 years. Models were adjusted for recipient age, sex, diabetes mellitus, Model for End-Stage Liver Disease score, duration on the liver waiting list, induction immunosuppression, steroid maintenance, hepatitis C infection, donor age and sex, local vs. shared organ, cold ischemia time, and previous liver transplantation status. In the univariable analysis, crossmatch status was not associated with recipient survival (log-rank p = 0.63), death-censored liver graft survival (log-rank p = 0.05), or death-censored kidney graft survival (log-rank p = 0.11). Compared with −XM, +XM recipients had a similar 1-year liver rejection rate, but higher kidney rejection rate (4.6% vs. 8.9%, p = 0.002). In the multivariable models, +XM status was not associated with deleterious long-term recipient, liver, or kidney grafts survival. −XM and +XM SLK transplantations have comparable long-term recipient, liver graft, and kidney survival with a slightly increased risk of early kidney allograft rejection in the +XM group. Crossmatch positivity in SLK transplantations should not influence the decision to use organs from a specific donor.

CONFLICT OF INTEREST

Nothing to report.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.